Internal Medicine, Pulmonary Disease · New York, NY
NPI
1891795787
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
404 Park Ave S, Suite 701
New York, NY, 10016
Phone (212) 685-6611
Groups this clinician bills Medicare through
Medicare paid, 2024
$486K
7,309 services
Medicare patients, 2024
939
Average age 77
Drug cost, 2024
$933K
2,836 prescriptions
Company payments, 2025
$808
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David L Kamelhar was code 99214 (office e&m - established), 1,500 times for 716 patients. In total David L Kamelhar billed 7,309 services in 18 codes, and Medicare paid $486K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,500 | 716 | $109.53 | $164K |
| 94726 Pulmonary Function Testing | Office | 1,489 | 840 | $50.88 | $76K |
| 94060 Pulmonary Function Testing | Office | 1,409 | 808 | $35.81 | $50K |
| 99213 Office E&M - Established | Office | 1,057 | 562 | $72.62 | $77K |
| 94729 Pulmonary Function Testing | Office | 813 | 683 | $51.66 | $42K |
| 99457 E&M - Miscellaneous | Office | 234 | 27 | $44.60 | $10K |
| 99205 Office E&M - New | Office | 195 | 195 | $185.62 | $36K |
| 99454 E&M - Miscellaneous | Office | 154 | 21 | $44.37 | $6,833 |
| 94010 Pulmonary Function Testing | Office | 83 | 71 | $24.92 | $2,068 |
| 99458 E&M - Miscellaneous | Office | 76 | 25 | $35.19 | $2,674 |
| 94618 Pulmonary Function Testing | Office | 75 | 74 | $30.51 | $2,288 |
| 95012 Pulmonary | Office | 62 | 59 | $17.82 | $1,105 |
| 99215 Office E&M - Established | Office | 56 | 53 | $164.01 | $9,185 |
| 94664 E&M - Miscellaneous | Office | 47 | 43 | $17.30 | $813 |
| 99204 Office E&M - New | Office | 29 | 29 | $149.13 | $4,325 |
By year: 2022 $434K for 5,717 services; 2023 $422K for 6,030 services; 2024 $486K for 7,309 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 17 | $8.65 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug David L Kamelhar prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 295 prescriptions and refills. In total David L Kamelhar wrote 2,836 Medicare prescriptions that cost $933K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 295 | 337 | 149 | $7,471 |
| Azithromycin Generic | 204 | 259 | 62 | $3,974 |
| Ethambutol Hcl Generic | 155 | 211 | 25 | $6,341 |
| Rifampin Generic | 152 | 204 | 21 | $6,190 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 142 | 212 | 38 | $132K |
| Spiriva Respimat Tiotropium Bromide | 141 | 200 | 37 | $104K |
| Famotidine Generic | 137 | 191 | 59 | $1,175 |
| Prednisone Generic | 133 | 210 | 47 | $1,297 |
| Montelukast Sodium Generic | 130 | 360 | 42 | $1,512 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 86 | 127 | 21 | $60K |
| Arnuity Ellipta Fluticasone Furoate | 75 | 111 | 21 | $22K |
| Qvar Redihaler Beclomethasone Dipropionate | 73 | 125 | 21 | $26K |
| Doxycycline Hyclate Generic | 70 | 70 | 48 | $656 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 68 | 83 | 23 | $37K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 64 | 81 | 19 | $50K |
Brand drugs: - claims; generic drugs: 1,733 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David L Kamelhar $808 ($808 in general payments such as food, travel and fees) from 8 companies. The largest payer was Insmed, Inc. with $261.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 15 | $261 |
| GlaxoSmithKline, LLC. GSK | 22 | $240 |
| Philips North America LLC PHG | 4 | $101 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $86.13 |
| Baxter Healthcare BAX | 2 | $40.62 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $37.5 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $23.19 |
| Electromed, Inc. ELMD | 1 | $17.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.